Barinthus Biotherapeutics plc revenue breakdown overview

Barinthus Biotherapeutics plc revenue for the last year amounted to 800.00 k USD, the most of which — 802.00 k USD — came from its highest performing source at the moment, Immunotherapies and Vaccines, the year earlier bringing 44.70 M USD. The greatest contribution to the revenue figure was made by United Kingdom and United States — last year it brought Barinthus Biotherapeutics plc 802.00 k USD, and the year before that — 44.70 M USD.